SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance

Giuseppe Borsani, Maria Teresa Bassi, Maria Pia Sperandeo, Alessandro De Grandi, Anna Buoninconti, Mirko Riboni, Marta Manzoni, Barbara Incerti, Antonio Pepe, Generoso Andria, Andrea Ballabio, Gianfranco Sebastio

Research output: Contribution to journalArticle

173 Citations (Scopus)

Abstract

Lysinuric protein intolerance (LPI, MIM 222700) is an autosomal recessive multisystem disorder found mainly in Finland and Italy. On a normal diet, LPI patients present poor feeding, vomiting, diarrhoea, episodes of hyperammoniaemic coma and failure to thrive. Hepatosplenomegaly, osteoporosis and a life-threatening pulmonary involvement (alveolar proteinosis) are also seen. LPI is caused by defective cationic amino acid (CAA) transport at the basolateral membrane of epithelial cells in kidney and intestine. Metabolic derangement is characterized by increased renal excretion of CAA, reduced CAA absorption from intestine and orotic aciduria. The gene causing LPI was assigned using linkage analysis to chromosome 14q11.2 near the T-cell receptor α/δ chains locus, and a critical region has been defined. We have identified two new transcripts (SLC7A8 and SLC7A7) homologous to amino acid transporters, highly expressed in kidney and mapping in the LPI critical region. Mutational analysis of both transcripts revealed that SLC7A7 (for solute carrier family 7, member 7) is mutated in LPI. In five Italian patients, we found either an insertion or deletion in the coding sequence, which provides evidence of a causative role of SLC7A7 in LPI. Furthermore, we detected a splice acceptor change resulting in a frameshift and premature translation termination in four unrelated Finnish patients. This mutation may represent the founder LPI allele in Finland.

Original languageEnglish
Pages (from-to)297-301
Number of pages5
JournalNature Genetics
Volume21
Issue number3
DOIs
Publication statusPublished - Mar 1999

Fingerprint

Membrane Transport Proteins
Finland
Amino Acids
Intestines
Pulmonary Alveolar Proteinosis
Kidney
Amino Acid Transport Systems
Failure to Thrive
Proteins
Coma
T-Cell Antigen Receptor
Italy
Osteoporosis
Vomiting
Diarrhea
Chromosomes
Epithelial Cells
Alleles
Diet
Mutation

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Borsani, G., Bassi, M. T., Sperandeo, M. P., De Grandi, A., Buoninconti, A., Riboni, M., ... Sebastio, G. (1999). SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance. Nature Genetics, 21(3), 297-301. https://doi.org/10.1038/6815

SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance. / Borsani, Giuseppe; Bassi, Maria Teresa; Sperandeo, Maria Pia; De Grandi, Alessandro; Buoninconti, Anna; Riboni, Mirko; Manzoni, Marta; Incerti, Barbara; Pepe, Antonio; Andria, Generoso; Ballabio, Andrea; Sebastio, Gianfranco.

In: Nature Genetics, Vol. 21, No. 3, 03.1999, p. 297-301.

Research output: Contribution to journalArticle

Borsani, G, Bassi, MT, Sperandeo, MP, De Grandi, A, Buoninconti, A, Riboni, M, Manzoni, M, Incerti, B, Pepe, A, Andria, G, Ballabio, A & Sebastio, G 1999, 'SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance', Nature Genetics, vol. 21, no. 3, pp. 297-301. https://doi.org/10.1038/6815
Borsani, Giuseppe ; Bassi, Maria Teresa ; Sperandeo, Maria Pia ; De Grandi, Alessandro ; Buoninconti, Anna ; Riboni, Mirko ; Manzoni, Marta ; Incerti, Barbara ; Pepe, Antonio ; Andria, Generoso ; Ballabio, Andrea ; Sebastio, Gianfranco. / SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance. In: Nature Genetics. 1999 ; Vol. 21, No. 3. pp. 297-301.
@article{1878991b79b443868c00b82a81fcafd4,
title = "SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance",
abstract = "Lysinuric protein intolerance (LPI, MIM 222700) is an autosomal recessive multisystem disorder found mainly in Finland and Italy. On a normal diet, LPI patients present poor feeding, vomiting, diarrhoea, episodes of hyperammoniaemic coma and failure to thrive. Hepatosplenomegaly, osteoporosis and a life-threatening pulmonary involvement (alveolar proteinosis) are also seen. LPI is caused by defective cationic amino acid (CAA) transport at the basolateral membrane of epithelial cells in kidney and intestine. Metabolic derangement is characterized by increased renal excretion of CAA, reduced CAA absorption from intestine and orotic aciduria. The gene causing LPI was assigned using linkage analysis to chromosome 14q11.2 near the T-cell receptor α/δ chains locus, and a critical region has been defined. We have identified two new transcripts (SLC7A8 and SLC7A7) homologous to amino acid transporters, highly expressed in kidney and mapping in the LPI critical region. Mutational analysis of both transcripts revealed that SLC7A7 (for solute carrier family 7, member 7) is mutated in LPI. In five Italian patients, we found either an insertion or deletion in the coding sequence, which provides evidence of a causative role of SLC7A7 in LPI. Furthermore, we detected a splice acceptor change resulting in a frameshift and premature translation termination in four unrelated Finnish patients. This mutation may represent the founder LPI allele in Finland.",
author = "Giuseppe Borsani and Bassi, {Maria Teresa} and Sperandeo, {Maria Pia} and {De Grandi}, Alessandro and Anna Buoninconti and Mirko Riboni and Marta Manzoni and Barbara Incerti and Antonio Pepe and Generoso Andria and Andrea Ballabio and Gianfranco Sebastio",
year = "1999",
month = "3",
doi = "10.1038/6815",
language = "English",
volume = "21",
pages = "297--301",
journal = "Nature Genetics",
issn = "1061-4036",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance

AU - Borsani, Giuseppe

AU - Bassi, Maria Teresa

AU - Sperandeo, Maria Pia

AU - De Grandi, Alessandro

AU - Buoninconti, Anna

AU - Riboni, Mirko

AU - Manzoni, Marta

AU - Incerti, Barbara

AU - Pepe, Antonio

AU - Andria, Generoso

AU - Ballabio, Andrea

AU - Sebastio, Gianfranco

PY - 1999/3

Y1 - 1999/3

N2 - Lysinuric protein intolerance (LPI, MIM 222700) is an autosomal recessive multisystem disorder found mainly in Finland and Italy. On a normal diet, LPI patients present poor feeding, vomiting, diarrhoea, episodes of hyperammoniaemic coma and failure to thrive. Hepatosplenomegaly, osteoporosis and a life-threatening pulmonary involvement (alveolar proteinosis) are also seen. LPI is caused by defective cationic amino acid (CAA) transport at the basolateral membrane of epithelial cells in kidney and intestine. Metabolic derangement is characterized by increased renal excretion of CAA, reduced CAA absorption from intestine and orotic aciduria. The gene causing LPI was assigned using linkage analysis to chromosome 14q11.2 near the T-cell receptor α/δ chains locus, and a critical region has been defined. We have identified two new transcripts (SLC7A8 and SLC7A7) homologous to amino acid transporters, highly expressed in kidney and mapping in the LPI critical region. Mutational analysis of both transcripts revealed that SLC7A7 (for solute carrier family 7, member 7) is mutated in LPI. In five Italian patients, we found either an insertion or deletion in the coding sequence, which provides evidence of a causative role of SLC7A7 in LPI. Furthermore, we detected a splice acceptor change resulting in a frameshift and premature translation termination in four unrelated Finnish patients. This mutation may represent the founder LPI allele in Finland.

AB - Lysinuric protein intolerance (LPI, MIM 222700) is an autosomal recessive multisystem disorder found mainly in Finland and Italy. On a normal diet, LPI patients present poor feeding, vomiting, diarrhoea, episodes of hyperammoniaemic coma and failure to thrive. Hepatosplenomegaly, osteoporosis and a life-threatening pulmonary involvement (alveolar proteinosis) are also seen. LPI is caused by defective cationic amino acid (CAA) transport at the basolateral membrane of epithelial cells in kidney and intestine. Metabolic derangement is characterized by increased renal excretion of CAA, reduced CAA absorption from intestine and orotic aciduria. The gene causing LPI was assigned using linkage analysis to chromosome 14q11.2 near the T-cell receptor α/δ chains locus, and a critical region has been defined. We have identified two new transcripts (SLC7A8 and SLC7A7) homologous to amino acid transporters, highly expressed in kidney and mapping in the LPI critical region. Mutational analysis of both transcripts revealed that SLC7A7 (for solute carrier family 7, member 7) is mutated in LPI. In five Italian patients, we found either an insertion or deletion in the coding sequence, which provides evidence of a causative role of SLC7A7 in LPI. Furthermore, we detected a splice acceptor change resulting in a frameshift and premature translation termination in four unrelated Finnish patients. This mutation may represent the founder LPI allele in Finland.

UR - http://www.scopus.com/inward/record.url?scp=0033017645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033017645&partnerID=8YFLogxK

U2 - 10.1038/6815

DO - 10.1038/6815

M3 - Article

VL - 21

SP - 297

EP - 301

JO - Nature Genetics

JF - Nature Genetics

SN - 1061-4036

IS - 3

ER -